P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY

• Y.-J. Gao,
• K.-N. Shen,
• L. Chang,
• J. Feng,
• L. Zhang,
• Y.-Y. Mao,
• X.-X. Cao,
• D.-B. Zhou,
• J. Li

Affiliations

Y.-J. Gao

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

K.-N. Shen

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

L. Chang

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

J. Feng

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

L. Zhang

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

Y.-Y. Mao

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

X.-X. Cao

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

D.-B. Zhou

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China

J. Li

1 Department of Hematology, Peking Union Medical College Hospital, Beijing, China